OHI Price Prediction Next Week
Analysis and Insights
To predict the stock price of Omega Healthcare Investors (OHI) for the next trading week, we analyze both technical indicators and recent news sentiment.
Technical Analysis:
OHI's stock price is currently trading at $36.88, with a 52-week range of $29.66 to $44.415. The stock has recently crossed above its 200-day moving average, a bullish signal. Key technical indicators include:
- RSI (14): 49.80 (neutral, not oversold)
- MACD: -0.09 (close to zero, potential bullish crossover)
- Stochastic Oscillator: %K (54.06) above %D (66.07), indicating bullish momentum
- Bollinger Bands: Price near lower band, suggesting potential bounce
- Fibonacci Levels: Pivot point at $36.84, close to current price
News Sentiment and Fundamental Analysis:
- OHI has a high dividend yield of 7.27%, making it attractive for income investors.
- Recent analyst ratings include a price target increase to $43 by RBC Capital, indicating confidence in the stock.
- The company reported upbeat quarterly sales and expects improving financial metrics due to recent investments.
Price Prediction and Recommendation:
Based on the bullish technical indicators and positive news sentiment, OHI is expected to rise next week. The stock is likely to test the Fibonacci resistance level of $37.85, with a target price of $38.50.
Recommendation: Buy OHI as the technical and fundamental factors align for a bullish outlook.
OHI Similar Chart Price Prediction
The price of OHI is predicted to go up 14.44%, based on the high correlation periods with DFS. The similarity of these two price pattern on the periods is 90.65%.
OHI
DFS
Up: 14.44%Similarity: 90.65%
OHI Revenue Forecast
OHI EPS Forecast
OHI FAQs
What is OHI revenue forecast for next quarter？
OHI Analyst's Forecast
Juan Sanabria
BMO Capital
Hold → Buy
2024-12-09
Price Target
$45
Upside
+15.83%
BMO Capital upgraded Omega Healthcare to Outperform from Market Perform with an unchanged price target of $45. The firm expects continued "robust" accretive acquisitions from Omega with its estimates modestly above the Street. The company has a strong balance sheet to drive earnings while its diversified tenant base "limits idiosyncratic credit risk," the analyst tells investors in a research note.
Michael Carroll
RBC Capital
Hold
2024-11-11
Price Target
$39 → $43
Upside
+7.42%
Kai Klose
Berenberg
Strong Buy
2024-10-18
Price Target
$45
Upside
+8.15%
